Price movement over the last 24 hours
Abeona Therapeutics Inc vs Reddit Inc — how do they compare? Abeona Therapeutics Inc trades at $6.79 (market cap $373.32M), while Reddit Inc trades at $195.01 (market cap $38.39B). The key difference: Reddit Inc is far larger — about 102.8× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Reddit Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | RDDT | |
|---|---|---|
Market Cap | $373.32M | $38.39B |
Sector | Health | Media |
52-Week High | $7.23 | $270.71 |
52-Week Low | $4.17 | $121.84 |
Enterprise Value | $228.22M | $35.64B |
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
Reddit (RDDT) trades at $200.67, up 3.13% today, reflecting strong momentum. The stock shows a bullish technical stance with moving averages aligned positively, though the RSI suggests potential overbought conditions. Fundamentally, the company exhibits robust revenue growth, with 2025 revenue at $2.2B and net income of $529.72M, supported by high gross margins of 91.37%. Recent earnings have mostly beaten expectations, and analyst sentiment is overwhelmingly positive with a consensus price target of $229.11. News highlights focus on AI safety initiatives and advertising growth.
The outlook for RDDT is favorable, driven by strong financial performance, expanding user engagement, and strategic AI investments. Key opportunities include sustained revenue growth and market share gains in social media. Risks involve competitive pressures, reliance on advertising revenue, and market volatility. With no sell ratings and solid cash flow generation, the stock presents a compelling case for growth-oriented investors, though valuation multiples remain elevated.
Trailing returns across standard periods
Latest headlines on both assets
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →